Document is current
Any future updates will be listed below
-
Authors
Klingel, Karin https://orcid.org/0000-0003-0203-2498
Tschöpe, Carsten
Yon, Dong Keon
Mensah, George A. https://orcid.org/0000-0002-0387-5326
Weber, Brittany N.
Kontorovich, Amy R. https://orcid.org/0000-0001-7400-5507
Lee, Sooji
Cooper, Leslie T.
Ammirati, Enrico https://orcid.org/0000-0002-1676-5257
- License Information
-
More Information
Article History
Accepted: 9 March 2026
First Online: 26 March 2026
Competing interests
: K.K. declares speaker honoraria from Alnylam and Pfizer. C.T. has received speaker honoraria and/or support for congress participation from AstraZeneca, Bayer, Novartis and Pfizer, and serves on the steering committee of the ARCHER trial (Cardiol Therapeutics). B.N.W. declares speaker honoraria, consulting and or Scientific Advisory Board membership for BMS, Kiniksa, Novo Nordisk and Oruka. L.T.C. is a consultant for BMS CardiolRx and Moderna, and a board member for Stromal Therapeutics. E.A. has received consultation fees from Hotgen Health Inc and Lexeo. The other authors declare no competing interests.
